Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

By Bilous Michael   Morey Adrienne   Armes Jane   Cummings Margaret   Francis Glenn  

Pathology, Vol. 38, Iss. 2, 2006-04 ,pp. : 120-124

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study

By Provenzano Elena   Hopper John   Giles Graham   Marr Georgina   Venter Deon   Armes Jane  

Pathology, Vol. 36, Iss. 3, 2004-06 ,pp. : 221-229

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparison of Preoperative Simultaneous Stereotactic Fine Needle Aspiration Biopsy and Stereotactic Core Needle Biopsy in Ductal Carcinoma In Situ of the Breast

By Leifland K   Lundquist H   Lagerstedt U   Svane G  

Acta Radiologica, Vol. 44, Iss. 2, 2003-03 ,pp. : 213-217

Blackwell Publishing

Access to resources Recommend Favorite

Common ALK gene rearrangement in Asian CD30⁺ anaplastic large cell lymphoma: an immunohistochemical and fluorescence in situ hybridisation (FISH) study on paraffin-embedded tissue

By Chin Tai Yan   Hua Kim Lian   Cheng Peh Suat  

Pathology, Vol. 35, Iss. 5, 2003-10 ,pp. : 436-443

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Update on atypical epithelial hyperplasia and ductal carcinoma in situ

By Simpson Jean F.  

Pathology, Vol. 41, Iss. 1, 2009-10 ,pp. : 36-39

Ashgate Publishing Ltd

Access to resources Recommend Favorite